OPKO Health, Inc. (FRA:XCY)

Market Cap	781.95M -24.8%
Revenue (ttm)	547.23M -9.7%
Net Income	-153.75M
EPS	-0.21
Shares Out	n/a
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Average Volume	n/a
Open	1.0104
Previous Close	0.9700
Day's Range	0.9770 - 1.0104
52-Week Range	0.9610 - 1.6560
Beta	n/a
RSI	41.02
Earnings Date	Feb 26, 2026

About OPKO Health

OPKO Health, Inc., a healthcare company, engages in the diagnostics and pharmaceuticals businesses in the United States, Ireland, Chile, Spain, Israel, Mexico, and internationally. The company’s Diagnostics segment operates BioReference Laboratories that offer laboratory testing services for the detection, diagnosis, evaluation, monitoring, and treatment of diseases, including esoteric testing, molecular diagnostics, anatomical pathology, genetics, women’s health, and correctional healthcare to physician offices, clinics, hospitals, employers, ...

• Industry: Medical Laboratories
• Founded: 2007
• Employees: 2,997
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: XCY

Financial Performance

In 2024, OPKO Health's revenue was $713.14 million, a decrease of -17.41% compared to the previous year's $863.50 million. Losses were -$53.22 million, -71.82% less than in 2023.

Financial numbers in USD